Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

Synthelabo reports agents for urinary incontinence

April 11, 1997

GelTex reports preliminary phase IIc results for RenaGel

April 10, 1997

Urologix's PMA for T3 System accepted for review

April 7, 1997

Hokuriku discloses agents for urinary incontinence

April 2, 1997

Anaritide and acute renal failure

April 1, 1997

Cheung Laboratories initiates preclinicals of BPH treatment system

March 27, 1997

Pharmacia & Upjohn seeks FDA approval for incontinence drug

March 27, 1997

Alpha-adrenoceptor blockers from SKB

March 27, 1997

Pharmacia & Upjohn prepares stereoisomers of FCE-28260

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...